Literature DB >> 8866362

A novel physiological function for platelet-derived growth factor-BB in rat dermis.

S A Rodt1, K Ahlén, A Berg, K Rubin, R K Reed.   

Abstract

1. The present experiments describe a role for platelet-derived growth factor-BB and cellular adhesion receptors towards extracellular matrix molecules (beta 1-integrins) in control of interstitial fluid pressure (Pif). 2. Pif was measured in rat skin with sharpened glass capillaries (3-7 microns) connected to a servocontrolled counter-pressure system. 3. The collagen and laminin-binding alpha 2 beta 1-integrin is involved in the control of Pif since subdermal injection (5 microliters) of monoclonal hamster anti-rat alpha 2 beta 1-integrin IgG (anti-alpha 2 beta 1) resulted in increased negativity of Pif. Control Pif averaged -0.88 +/- 0.23 mmHg (+/- S.D.) and decreased to -2.50 +/- 0.35 mmHg (P < 0.05) and -3.88 +/- 1.45 mmHg (P < 0.05) at anti-alpha 2 beta 1 concentrations of 0.56 and 1.12 mg ml-1, respectively. 4. The effect of anti-alpha 2 beta 1 was abolished when platelet-derived growth factor-BB (PDGF-BB) (200 ng ml-1) was injected together with anti-alpha 2 beta 1. 5. The time- and dose-responses of PDGF-BB to counteract increased negativity of Pif were studied further using dextran anaphylaxis as an experimental model inducing increased negativity of Pif in skin. Control Pif averaged -0.33 +/- 0.43 mmHg and fell to -4.10 +/- 1.47 mmHg within 10 min after dextran (P < 0.01). Subsequent subdermal injection of PDGF-BB at 200 ng ml-1 normalized Pif in 10-20 min which became -1.37 +/- 1.23 mmHg (P < 0.01 versus dextran, P > 0.05 versus control). PDGF-BB had little or no effect at 50 ng ml-1. PDGF-AA and basic fibroblast growth factor had no effect on Pif. 6. The in vivo function reported for PDGF-BB has not been described previously and provides further evidence for active participation of connective tissue cells in control of Pif by altering tension on extracellular matrix structures.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8866362      PMCID: PMC1160735          DOI: 10.1113/jphysiol.1996.sp021584

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  34 in total

Review 1.  New perspectives in cell adhesion: RGD and integrins.

Authors:  E Ruoslahti; M D Pierschbacher
Journal:  Science       Date:  1987-10-23       Impact factor: 47.728

Review 2.  Integrin, a transmembrane glycoprotein complex mediating cell-substratum adhesion.

Authors:  C A Buck; A F Horwitz
Journal:  J Cell Sci Suppl       Date:  1987

Review 3.  Integrins: a family of cell surface receptors.

Authors:  R O Hynes
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

4.  Expression of platelet-derived growth factor receptors is induced on connective tissue cells during chronic synovial inflammation.

Authors:  K Rubin; L Terracio; L Rönnstrand; C H Heldin; L Klareskog
Journal:  Scand J Immunol       Date:  1988-03       Impact factor: 3.487

5.  Mechanisms behind increased dermal imbibition pressure in acute burn edema.

Authors:  T Lund; H Onarheim; H Wiig; R K Reed
Journal:  Am J Physiol       Date:  1989-04

6.  Two classes of PDGF receptor recognize different isoforms of PDGF.

Authors:  C E Hart; J W Forstrom; J D Kelly; R A Seifert; R A Smith; R Ross; M J Murray; D F Bowen-Pope
Journal:  Science       Date:  1988-06-10       Impact factor: 47.728

7.  Glomerular epithelial and mesangial cells differentially modulate the binding specificities of VLA-1 and VLA-2.

Authors:  D L Mendrick; D M Kelly; S S duMont; D J Sandstrom
Journal:  Lab Invest       Date:  1995-03       Impact factor: 5.662

8.  Macromolecular basis of globular protein exclusion and of swelling pressure in loose connective tissue (umbilical cord).

Authors:  F A Meyer
Journal:  Biochim Biophys Acta       Date:  1983-02-22

9.  Binding of different dimeric forms of PDGF to human fibroblasts: evidence for two separate receptor types.

Authors:  C H Heldin; G Bäckström; A Ostman; A Hammacher; L Rönnstrand; K Rubin; M Nistér; B Westermark
Journal:  EMBO J       Date:  1988-05       Impact factor: 11.598

10.  Induction of platelet-derived growth factor receptor expression in smooth muscle cells and fibroblasts upon tissue culturing.

Authors:  L Terracio; L Rönnstrand; A Tingström; K Rubin; L Claesson-Welsh; K Funa; C H Heldin
Journal:  J Cell Biol       Date:  1988-11       Impact factor: 10.539

View more
  26 in total

1.  Platelet-derived growth factor beta receptor regulates interstitial fluid homeostasis through phosphatidylinositol-3' kinase signaling.

Authors:  R Heuchel; A Berg; M Tallquist; K Ahlén; R K Reed; K Rubin; L Claesson-Welsh; C H Heldin; P Soriano
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  Small-molecule protein tyrosine kinase inhibitors for the treatment of metastatic prostate cancer.

Authors:  Gary E Gallick; Paul G Corn; Amado J Zurita; Sue-Hwa Lin
Journal:  Future Med Chem       Date:  2012-01       Impact factor: 3.808

Review 3.  The platelet-derived growth factor receptor as a therapeutic target.

Authors:  Nancy L Lewis
Journal:  Curr Oncol Rep       Date:  2007-03       Impact factor: 5.075

4.  Pleural adverse drugs reactions and protein kinase inhibitors: Identification of suspicious targets by disproportionality analysis from VigiBase.

Authors:  Julien Mahé; Emilie Patras de Campaigno; Anne-Laure Chené; Jean-Louis Montastruc; Fabien Despas; Pascale Jolliet
Journal:  Br J Clin Pharmacol       Date:  2018-08-05       Impact factor: 4.335

Review 5.  Fulminant capillary leak syndrome in a patient with systemic sclerosis treated with imatinib mesylate.

Authors:  Monique E Hinchcliff; Jon Lomasney; Julie A Johnson; John Varga
Journal:  Rheumatology (Oxford)       Date:  2016-06-23       Impact factor: 7.580

6.  Effect of alpha-trinositol on interstitial fluid pressure, oedema generation and albumin extravasation in experimental frostbite in the rat.

Authors:  A Berg; P Aas; T Gustafsson; R K Reed
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

7.  Effect of platelet-derived growth factor receptor-beta inhibition with STI571 on radioimmunotherapy.

Authors:  Janina Baranowska-Kortylewicz; Michio Abe; Kristian Pietras; Zbigniew P Kortylewicz; Takashi Kurizaki; Jessica Nearman; Janna Paulsson; R Lee Mosley; Charles A Enke; Arne Ostman
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

8.  A simple method for measuring interstitial fluid pressure in cancer tissues.

Authors:  Ugur Ozerdem; Alan R Hargens
Journal:  Microvasc Res       Date:  2005-08-31       Impact factor: 3.514

9.  Concurrent male gynecomastia and testicular hydrocele after imatinib mesylate treatment of a gastrointestinal stromal tumor.

Authors:  Hawk Kim; Heung-Moon Chang; Min-Hee Ryu; Tae-Won Kim; Hee-Jung Sohn; So-Eun Kim; Hye-Jin Kang; Sarah Park; Jung-Shin Lee; Yoon-Koo Kang
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

10.  Combined anti-angiogenic therapy targeting PDGF and VEGF receptors lowers the interstitial fluid pressure in a murine experimental carcinoma.

Authors:  Agnieszka Kłosowska-Wardega; Yoko Hasumi; Mikhail Burmakin; Aive Ahgren; Linda Stuhr; Ingrid Moen; Rolf K Reed; Kristofer Rubin; Carina Hellberg; Carl-Henrik Heldin
Journal:  PLoS One       Date:  2009-12-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.